Hikma Pharmaceuticals (HKMPF) News Today $22.56 0.00 (0.00%) (As of 11/21/2024 ET) Add Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Hikma Pharmaceuticals: Strategic Growth and Attractive Valuation Reinforce Buy RatingNovember 8, 2024 | markets.businessinsider.comHikma Pharmaceuticals remains steady Tuesday, underperforms marketOctober 1, 2024 | marketwatch.comHikma Pharmaceuticals PLC (OTCMKTS:HKMPF) Short Interest Down 17.0% in AugustHikma Pharmaceuticals PLC (OTCMKTS:HKMPF - Get Free Report) was the recipient of a large drop in short interest in August. As of August 15th, there was short interest totalling 1,574,300 shares, a drop of 17.0% from the July 31st total of 1,896,300 shares. Based on an average daily volume of 1,300 shares, the days-to-cover ratio is currently 1,211.0 days.August 31, 2024 | marketbeat.comHikma Pharmaceuticals falls Friday, underperforms marketAugust 30, 2024 | marketwatch.comJazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High PricesAugust 28, 2024 | msn.comHikma Pharmaceuticals falls Friday, still outperforms marketAugust 16, 2024 | marketwatch.comBuy Rating Affirmed for Hikma Pharmaceuticals on Strong Performance and Growth ProspectsAugust 15, 2024 | markets.businessinsider.comHikma Pharmaceuticals PLC (HKMPF) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comHikma Pharmaceuticals reports 1H resultsAugust 9, 2024 | msn.comHikma Pharmaceuticals PLC (OTCMKTS:HKMPF) Sees Large Growth in Short InterestHikma Pharmaceuticals PLC (OTCMKTS:HKMPF - Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 1,849,700 shares, a growth of 6.2% from the April 15th total of 1,741,900 shares. Based on an average daily trading volume, of 200 shares, the short-interest ratio is presently 9,248.5 days.May 16, 2024 | marketbeat.comCollegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In USApril 29, 2024 | markets.businessinsider.comHikma Pharmaceuticals PLC goes ex dividend tomorrowMarch 20, 2024 | msn.comOptimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past weekMarch 18, 2024 | finance.yahoo.comHikma Pharmaceuticals PLC (HKMPF)February 27, 2024 | finance.yahoo.comDrugmaker Hikma expects profit to be slightly lower in 2024February 22, 2024 | msn.comHikma Pharma FY Profit IncreasesFebruary 22, 2024 | markets.businessinsider.comHikma Pharmaceuticals did not report suspicious opioid orders for 15 years, NC Attorney General Josh Stein saysFebruary 1, 2024 | msn.comHikma Pharmaceuticals Agrees in Principle to Pay up to $115M in US Opioid SettlementFebruary 1, 2024 | marketwatch.comAd firm Publicis, drugmaker Hikma settle US opioid cases for $500 millionFebruary 1, 2024 | finance.yahoo.comUPDATE 1-Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 millionFebruary 1, 2024 | finance.yahoo.comHikma Pharmaceuticals PLC's (LON:HIK) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?January 29, 2024 | finance.yahoo.comThe one-year decline in earnings might be taking its toll on Hikma Pharmaceuticals (LON:HIK) shareholders as stock falls 3.3% over the past weekOctober 5, 2023 | finance.yahoo.comStocks Open Lower, Weighed Down by Rising Bond YieldsOctober 3, 2023 | finance.yahoo.comRakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North AfricaAugust 10, 2023 | finance.yahoo.comHikma Appoints Bill Larkins as President of Injectables BusinessAugust 9, 2023 | marketwatch.comHikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseasesJuly 26, 2023 | finance.yahoo.comSelling Hikma Pharmaceuticals After A 40% Share Price Gain In 7 MonthsMay 6, 2023 | msn.comHikma Pharmaceutical appoints Injectables lead Mishlawi as new CEOApril 12, 2023 | lse.co.ukHikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1April 12, 2023 | nasdaq.comHikma Pharmaceuticals Appoints Riad Mishlawi CEOApril 12, 2023 | marketwatch.comHikma Pharma names Mishlawi as next CEOApril 12, 2023 | msn.comThose who invested in Hikma Pharmaceuticals (LON:HIK) five years ago are up 57%April 4, 2023 | finance.yahoo.comHikma Pharmaceuticals rises Thursday, still underperforms marketMarch 18, 2023 | marketwatch.comHikma Pharmaceuticals falls Monday, still outperforms marketMarch 15, 2023 | marketwatch.comHikma expands impact in Canada with launches of new sterile injectable medicinesMarch 9, 2023 | finance.yahoo.comIs Hikma Pharmaceuticals PLC's (LON:HIK) Recent Stock Performance Influenced By Its Fundamentals In Any Way?February 27, 2023 | finance.yahoo.comHikma Pharmaceutical FY EPS 83.6cFebruary 23, 2023 | marketwatch.comHikma accuses Amarin of suppressing generic versions of heart pillFebruary 22, 2023 | finance.yahoo.comHikma Pharmaceuticals to Buy Generic Drug Maker Roxane for $2.65 BillionDecember 28, 2022 | thestreet.comHikma Pharmaceuticals Stock (OTC:HKMPF), Earnings Estimates, EPS, and RevenueNovember 5, 2022 | benzinga.comCould The Market Be Wrong About Hikma Pharmaceuticals PLC (LON:HIK) Given Its Attractive Financial Prospects?September 20, 2022 | finance.yahoo.comHKMPF Hikma Pharmaceuticals PLCSeptember 10, 2022 | seekingalpha.comHikma Pharmaceuticals PLC HKMPF Stock ChartSeptember 9, 2022 | morningstar.comHikma Pharmaceuticals PLC 2022 Q2 - Results - Earnings Call PresentationAugust 5, 2022 | seekingalpha.comHikma Pharma slides on lower generics guidanceAugust 4, 2022 | proactiveinvestors.comHikma Pharmaceuticals Plc 1H Rev $1.21BAugust 4, 2022 | marketwatch.comHikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 32% Above Their Intrinsic Value EstimateJune 10, 2022 | finance.yahoo.comHikma Pharma CEO Siggi Olafsson Resigns - Quick FactsMay 24, 2022 | markets.businessinsider.comFTSE 100 soars after Wall St 'relief rally' and ahead of Bank of England decision but Hikma dropsMay 5, 2022 | proactiveinvestors.com.auHikma Pharmaceuticals PLC: Hikma confirms that it has not signed a licensing agreement with Opiant PharmaceuticalsApril 29, 2022 | finanznachrichten.de Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. HKMPF Media Mentions By Week HKMPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HKMPF News Sentiment▼0.000.46▲Average Medical News Sentiment HKMPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HKMPF Articles This Week▼00▲HKMPF Articles Average Week Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HKMPF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
